<i>In vivo</i> Generation of Angiostatin Isoforms by Administration of a Plasminogen Activator and a Free Sulfhydryl Donor: A Phase I Study of an Angiostatic Cocktail of Tissue Plasminogen Activator and Mesna
Gerald A. Soff(University of Miami), Timothy M. Kuzel(Rush University), Brenda Martone(Northwestern University), Alfred Rademaker(Northwestern University), Jennifer A. Doll(Northwestern University), Hao Wang(University of Mississippi), Deborah L. Cundiff(Northwestern University), Keyi Jiang(Northwestern University)
Cited by 25
Related Papers
Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma
|Journal of Clinical Oncology|2001|610
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
Treatment of <i>Staphylococcus aureus</i> Colonization in Atopic Dermatitis Decreases Disease Severity
|PEDIATRICS|2009|477
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model
|Journal of Clinical Oncology|2015|419
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
|Critical Reviews in Oncology/Hematology|2018|268